Abbrea Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
$266K Sell
253
-15
-6% -$15.8K 0.04% 200
2024
Q1
$258K Hold
268
0.03% 223
2023
Q4
$235K Buy
+268
New +$235K 0.03% 222